Richard Adam Nagle

Wound Solutions Ltd. develops wound healing care therapies. Its products and technologies provide diagnostic information to medical practitioners to enable improved healing programmes. The company’s current products ensure patients to wear their compression bandages and guide them to follow treatment programmes that improve time to healing. It specializes in medical devices, wound care, medical technology and venous leg ulcers treatments. The company was founded by Julian Michael Edward Lee and Richard Adam Nagle on June 11, 2003 and is headquartered in London, GB.

Part of Quintiles Transnational Corp., Innovex LP is a company that provides contract product development services. The company is based in Durham, NC.

Cardionetics Ltd. provides hardware and software solutions. It specializes in developing systems for diagnostic, monitoring, and screening purposes to help patients and healthcare professionals. The company was founded on April 12, 1995 and is headquartered in Hants, the United Kingdom.

Part of Quintiles Transnational Corp., Cardiac Alert is a British company that provides centralized electrocardiogram monitoring services for international clinical trials. The company is based in Chelsea, UK. Cardiac Alert was acquired by Quintiles Transnational Corp. on June 29, 1998.

ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA.

IR 2018 Ltd. develops human proteins for the treatment of rheumatoid arthritis. The company was founded by Gabriel S. Panayi and Jerry S. Lanchbury in August 6, 2001 and is headquartered in Great Shelford, the United Kingdom.

Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom.

Phico Therapeutics Ltd. develops antibiotic bacteria resistant technology. Its products include SASPject PT1.2 used for intra-nasal decolonization, SASPject PT3.1 used for intra-abdominal infections and SASPject PT4 used for both the infections. The company was founded by Dr. Heather Fairhead and is headquartered in Cambridge, the United Kingdom.